New Hope in Cancer Treatment: Combining Regorafenib with Chemotherapy
A pioneering study reveals significant survival benefits for advanced oesophagogastric cancer patients.
Topline:
The latest research demonstrates that adding regorafenib to nivolumab and chemotherapy can significantly improve outcomes for patients with advanced oesophagogastric adenocarcinoma, marking a substantial advancement in the fight against this challenging disease.
